home / stock / nvus / nvus news

NVUS News and Press, Novus Therapeutics Inc. From 02/04/19

Stock Information
Company Name: Novus Therapeutics Inc.
Stock Symbol: NVUS
Market: NASDAQ
Menu
NVUS NVUS Quote NVUS Short NVUS News NVUS Articles NVUS Message Board
Get NVUS Alerts

News, Short Squeeze, Breakout and More Instantly...
NVUS - Microcaps dominate midday movers

Gainers: Maxwell Technologies (NASDAQ: MXWL ) +50% . Therapix Biosciences (NASDAQ: TRPX ) +24% . Continental Materials (NYSEMKT: CUO ) +24% . PHI (NASDAQ: PHII ) +22% . Orgenesis (NASDAQ: ORGS ) +19% . The Ultimate Software Group (NASDAQ: ULTI ) +20% . Aileron Therapeutics (NASDAQ: ...
NVUS - Novus up 15% on advancement of OP0201

Thinly traded nano cap Novus Therapeutics ( NVUS +14.9% ) is up on average volume following its updates on clinical trials supporting lead drug OP0201. More news on: Novus Therapeutics, Healthcare stocks news, Stocks on the move, Read more ...

NVUS - Novus Therapeutics Advances OP0201 Development Program Across Several Clinical Trials

Screening Initiated for Phase 1 Pharmacodynamic Effects Trial (Study C-001) Screening Initiated for Second Cohort of Phase 1 Trial in Healthy Adults (Study C-002) Enrollment Completed in Phase 1 Trial in Adults with Acute Otitis Media (Study C-004) New Phase 2a Trial i...

NVUS - Microcaps mostly among midday movers

Gainers: Energous Corporation (NASDAQ: WATT ) +95% . BioXcel Therapeutics (NASDAQ: BTAI ) +81% . CounterPath (NASDAQ: CPAH ) +25% . Novus Therapeutics (NASDAQ: NVUS ) +21% . LiveXLive Media (NASDAQ: LIVX ) +19% . Netshoes (NYSE: NETS ) +17% . Avadel Pharmaceuticals (NASDAQ: AVDL ) ...
NVUS - Midday Gainers / Losers (09/07/2018)

Gainers:  OKTA +20% . NVUS +17% . XENE +16% . NX +16% . DRNA +15% . ZEAL +15% . SHLO +15% . TIS +13% . FIVE +13% . MCFT +11% . More news on: Okta, Inc., Novus Therapeutics, Xenon Pharmaceuticals, Stocks on the move, , Read more ...

NVUS - Novus Therapeutics to Postpone Offering of Common Stock

Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (“ENT”), today announced that it has elected to postpone the previously announced public offering of its common st...

NVUS - Premarket Gainers as of 9:05 am (09/07/2018)

NVUS +37%  on regaining its 24% slide. More news on: Novus Therapeutics, Okta, Inc., Five Below, Stocks on the move, , Read more ...

NVUS - Novus Therapeutics up 41% premarket

Thinly traded nano cap Novus Therapeutics (NASDAQ: NVUS ) is up  41%  premarket on increased volume, poised to regain the week's  24%  slide and then some. On Tuesday after the close, it announced a 6M-share stock offering although the price was not released. More news ...

Previous 10 Next 10